By Professor Nadine Ezard

Conference Papers

Heijstee N; Black E; Black E; Demirkol A; Mills L; Deacon RM; Mammen K; Dunlop AJ; Ezard N; Montebello M; Reid D; Childs S; Lintzeris N, 2021, 'WHO WE ARE HELPING: DESCRIBING DEMOGRAPHIC, HEALTH AND SOCIAL FACTORS ASSOCIATED WITH PRINCIPAL DRUG OF CONCERN, ALCOHOL USE AND ALCOHOL-RELATED HARMS, IN THE AUSTRALIAN ALCOHOL AND OTHER DRUG TREATMENT-SEEKING POPULATION', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S79 - S79, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200197&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lamoury F; Bajis S; Hajarizadeh B; Marshall A; Martinello M; Ivanova E; Catlett B; Mowat Y; Marks P; Amin J; Smith J; Ezard N; Cock V; Hayllar J; Persing D; Kleman M; Cunningham P; Dore G; Applegate T; Grebely J, 2018, 'Evaluation of the Xpert fingerstick HCV viral load assay', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. S167 - S167, presented at International Liver Congress (ILC), FRANCE, Paris, 11 April 2018 - 15 April 2018, http://dx.doi.org/10.1016/S0168-8278(18)30546-4

Grebely J; Lamoury F; Hajarizadeh B; Mowat Y; Marshall A; Bajis S; Marks P; Amin J; Smith J; Edwards M; Gorton C; Ezard N; Persing D; Kleman M; Cunningham P; Catlett B; Dore G; Applegate TL, 2017, 'Field evaluation of Xpert (R) HCV Viral Load point-of-care test for detection of hepatitis C virus infection by venipuncture-collected and finger-stick capillary whole-blood samples', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, pp. S709 - S709, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)31900-1

Conference Posters

Siefried K; Acheson L; Dunlop A; Lintzeris N; Christmass M; Bonomo Y; Arunogiri S; Hayllar J; Ezard N, 2021, 'A clinical research network approach to a trial of lisdexamfetamine for the treatment of acute methamphetamine withdrawal', Virtual, Vol. 40, pp. S132 - S133, presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

Siefried K; Ezard N; Christmass M; Hayllar J; Ali R, 2021, 'Towards an Australian clinical research network for methamphetamine and emerging drugs - outcomes of the National Centre for Clinical Research on Emerging Drugs Methamphetamine and Emerging Drugs Clinical Research Network Working Group', Virtual, Vol. 40, pp. S133 - S134, presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

Acheson L; Williams BHM; Farrell M; McKetin R; Ezard N; Siefried K, 2021, 'Pharmacological treatment for methamphetamine withdrawal: a systematic review and meta-analysis of randomised controlled trials', Virtual, presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

Black E; Deacon RM; Mills L; Mammen K; Dunlop A; Ezard N; Montebello M; Bruno R; Shakeshaft A; Farrell M; Holmes J; Reid D; Childs S; Siefried K; Cretikos M; Lintzeris N, 2021, 'Starting treatment in public drug and alcohol services in New South Wales: What can electronic medical records tell us about amphetamine type stimulant use?', Virtual, presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

May R; Ezard N; Siefried K; Bruno R, 2021, 'Neurocognitive changes in adults with methamphetamine dependence treated with lisdexamfetamine compared with those with additional positive screening for childhood ADHD', presented at International Medicine in Addiction Conference, 26 February 2021 - 28 February 2021

Bolton A; Spooner C; Harris M; Ezard N, 2019, '"Ice" in general practice. Barriers & enablers to care in GP for people who regularly use methamphetamine: a protocol for a qualitative study (Poster)', Adelaide, presented at Australian Association for Academic Primary Care (AAAPC), 12 July 2019

Ezard N; Dunlop AJ; Clifford B; Bruno R; Siefried KJ; Carr A; Lintzeris N, 2019, 'Safety of oral lisdexamfetamine in adults with methamphetamine dependence: a dose-escalating phase-2 study', San Antonio, Texas, USA, presented at The College on Problems of Drug Dependence 81st Annual Scientific Meeting, San Antonio, Texas, USA, 15 June 2019 - 19 July 2019

Ezard N; Siefried KJ; Peacock A, 2019, 'Developing a national prompt response network for Australia', Amsterdam, The Netherlands, presented at The 11th International Conference on Nightlife, Substance Use and Related Health Issues, Amsterdam, The Netherlands, 15 May 2019 - 17 May 2019

Siefried KJ; Peacock A; Ezard N, 2019, 'Towards a prompt response network for Australia: coordinated and rapid communication of information about events of concerns related to emerging substances', Maastricht, The Netherlands, presented at Sixth International Conference on Novel Psychoactive Substances, Maastricht, The Netherlands, 08 April 2019 - 09 April 2019

Bolton A; Spooner C; Ezard N; Harris M, 2019, 'Caring for methamphetamine users in General Practice: interim results', Adelaide, presented at GP19, Adelaide

Conference Presentations

Siefried K; Clifford B; Acheson L; Ezard N, 2023, 'Innovations beyond BC: Lisdexamfetamine for the treatment of methamphetamine use disorder and withdrawal', presented at The 5th Annual BC Substance Use Conference, Vancouver, Canada, 20 April 2023 - 23 April 2023

Hill P; Clifford B; Brown J; Dessauer P; Oh G; Lyons T; Herbert A; McKinnon G; Lamb M; Crawford S; Mason C; Siefried K; Ezard N, 2023, 'Strength in solidarity: Bringing together diverse local stakeholders to disseminate public drug information (presented on behalf of the Prompt Response Network)', presented at Harm Reduction International, Melbourne, Australia, 16 April 2023 - 19 April 2023, https://hr23.hri.global/programme/

Ezard N; Clifford B; Siefried K; Acheson L, 2022, 'Safety and tolerability of lisdexamfetamine for  methamphetamine dependence and withdrawal, early experience from Australia: The LiMA Trial and OLAM pilot', presented at Annual Meeting Conference of the Norwegian Association for Addiction Medicine, Bergen, Norway, 02 November 2022

Siefried K; McKetin R; Bedi G; Brett J; Arunogiri S; Dunlop A; Lintzeris N; Ezard N, 2021, 'Symposium: An update on pharmacotherapy trials for substance use disorder - methamphetamine type and withdrawal in Australia', presented at The APSAD Scientific Drug and Alcohol Conference, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

Siefried K; Arunogiri S; Brett J; McKetin R; Acheson LS; Knock E; Farrell M; Dunlop A; Lintzeris N; Ezard N, 2021, 'The future of pharmacotherapy clinical trials in Australia: the OLAM trial; the MOXY trial; the PSIMA trial; the TINA trial', presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

Siefried K; Nguyen Q; Ezard N, 2019, 'An Australian clinical research priority setting study for substance use disorder due to methamphetamine and emerging drugs of concern', presented at Lisbon Addictions 2019: The Third European Conference on Addictive Behaviours and Dependencies, Lisbon, Portugal, 23 October 2019 - 25 October 2019

Ezard N; Acheson LS; Siefried KJ; Leicester OM; Rodgers C; Malone V; Clifford B; Bruno R, 2019, 'Substance use sex index (SUSI): A new behaviour change assessment tool', presented at Lisbon Addictions 2019: The Third European Conference on Addictive Behaviours and Dependencies, Lisbon, Portugal, 23 October 2019 - 25 October 2019

Leung S; Deacon R; Rivas G; Monds L; Cubitt T; Nielsen S; Larance B; Ezard N; Lintzeris N, 2014, 'CHANGES IN ALPRAZOLAM USE AND RELATED HARM AMONG OPIOID TREATMENT PROGRAM CLIENTS FOLLOWING ITS RESCHEDULING TO A SCHEDULE 8 MEDICATION'

Lucas C; Ezard N; Day R, 2013, 'SYNTHETIC CANNABINOID USE: THE IMPORTANCE OF SURVEILLANCE', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326649400152&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts

Freestone J; Ezard N; Brett J; Roberts DM; Murray J; Prestage G; Hammoud M; Siefried KJ, 2022, '"Sometimes I have a duty of care not to call 000": Reported practices, attitudes and factors influencing consumer responses to GHB overdose', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S64 - S64, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700111&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Knock E; Ezard N; Day R; Siefried KJ; Liknaitzky P; Ross M; Albert S; Brett J, 2022, 'A study protocol for the PsiMA trial: Psilocybin assisted psychotherapy for methamphetamine use disorder', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S82 - S82, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hill PL; Siefried KJ; Tzanetis S; Peacock A; Lenton S; Ezard N, 2022, 'An Australian national Prompt Response Network for emerging drugs', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S73 - S73, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700127&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Acheson LS; Gordon C; Ezard N; Lintzeris N; Dunlop AJ; Brett J; Rodgers C; Gill A; Christmass M; McKetin R; Farrell M; Shoptaw S; Siefried KJ, 2022, 'An exploratory analysis of actigraphy and sleep diaries in a methamphetamine withdrawal clinical trial', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S23 - S24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Peacock A; Bruno R; Barratt MJ; Ezard N; Hill PL; Harrod ME; Brown JA; Page R; Keygan J; Sumnall H; Sutherland R, 2022, 'Awareness of, and behavioural responses to, drug alerts in Australia: Findings from the Ecstasy and Related Drugs Reporting System and the Illicit Drug Reporting System', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S108 - S108, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700185&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reilly R; Ramp J; Morton C; McKetin R; Butt J; Ezard N; Dunlop AJ; Conigrave KM; Quinn B; Treloar C; Gray D; Sivak L; Lockton J; Whetham H; Ward J, 2022, 'Lessons from the evaluation of a novel web-app to assist Aboriginal and Torres Strait Islander people to reduce or stop using methamphetamine: We can do this', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S117 - S118, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700202&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mills L; Mammen K; Deacon RM; Black E; Montebello M; Bruno R; Dunlop AJ; Ezard N; Shakeshaft A; Farrell M; Holmes J; Reid D; Childs S; Siefried KJ; Lintzeris N, 2022, 'Outcomes for clients in opioid treatment programs who use amphetamine type substances: Results from a retrospective analysis of routinely-collected clinical data', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S96 - S97, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700167&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bascombe F; Siefried KJ; Ezard N, 2022, 'Strengthening first-line support for Australians who use drugs, their friends and families: A training needs analysis for alcohol and other drug helplines for calls relating to methamphetamine and emerging drugs of concern', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S27 - S28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Clifford B; Shine P; Lo N; Stockwell T; Haber PS; Baldry E; Day CA; Dobbins T; Peacock A; Pauly B; Lintzeris N; Dolan K; Macklin B; Siefried KJ; Brett J; Dunlop AJ; Ezard N, 2022, 'The AusMAP study: A protocol for a randomised, controlled feasibility study of a managed alcohol program in Australia', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S44 - S45, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Williams BH; Acheson LS; Farrell M; McKetin R; Ezard N; Siefried KJ; Farrell M, 2022, 'PHARMACOLOGICAL TREATMENT FOR METHAMPHETAMINE WITHDRAWAL: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS', in AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, SAGE PUBLICATIONS LTD, Vol. 56, pp. 208 - 209

Siefried KJ; Nguyen QA; Ezard N; Christmass M; Ali R, 2019, 'A rapid clinical research priority setting study for substance use disorder due to methamphetamine and emerging drugs of concern in Australia', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991

Sandra S; Demerikol A; Branezac M; Ezard N; Siefried KJ; Acheson LS; Bascombe F; Tremonti C; Haber P; Lintzeris N, 2019, 'Are we detoxing the right people, in the right setting and in the right way? A rapid review of the literature on withdrawal management', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991

Black E; Deacon RM; Mills L; Dunlop A; Ezard N; Bruno R; Shakeshaft A; Farrell M; Holmes J; Cretikos MA; Montebello M; Reid D; Childs S; Siefried KJ; Mammen K; Lintzeris N, 2019, 'Characteristics and treatment outcomes of the drug treatment population in New South Wales: Focus on amphetamine type stimulants', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991

Acheson LS; Murray E; Clifford B; Siefried KJ; Matthews GV; Ezard N, 2019, 'Optimising care for people who inject drugs: A retrospective medical record review of staphylococcus aureus bactaraemia treatment', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991

Nguyen QA; Middleton P; Herman D; Li K; Grundy E; Li E; Siefried KJ; Malone V; Kay-Lambkin F; Ezard N, 2019, 'What's in an app? Incorporating an automated consent procedure to recruit those who use methamphetamine to a harm reduction and early intervention smartphone-based application clinical trial', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991

Reilly R; McKetin R; Butt J; Smout M; Clark Y; Roe Y; Ezard N; Dunlop AJ; Conigrave KM; Quinn B; Treloar C; Gray D; Wilkes E; Fisher I; Longbottom W; Ward J, 2019, 'A NOVEL WEB-APP TO ASSIST ABORIGINAL AND TORRES STRAIT ISLANDER PEOPLE TO REDUCE OR STOP USING METHAMPHETAMINE: WE CAN DO THIS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S86 - S86, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100216&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bolton A; Spooner C; Ezard N; Harris M, 2019, 'BARRIERS AND ENABLERS TO THE PROVISION OF STRUCTURED HEALTHCARE TO PEOPLE WHO REGULARLY USE METHAMPHETAMINE IN GENERAL PRACTICE: A QUALITATIVE STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S30 - S30

Black E; Deacon RM; Mills L; Dunlop AJ; Ezard N; Bruno R; Shakeshaft A; Farrell M; Holmes J; Cretikos MA; Montebello M; Reid D; Childs S; Siefried KJ; Mammen K; Lintzeris N, 2019, 'CHARACTERISTICS AND TREATMENT OUTCOMES OF THE DRUG TREATMENT POPULATION IN NEW SOUTH WALES: FOCUS ON AMPHETAMINE TYPE STIMULANTS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S27 - S28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100070&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Peacock A; Bruno R; Barratt M; Sutherland R; Hughes C; Gibbs D; Grigg J; Uporova J; Karlsson A; Kelly G; Dietze PM; Salom C; Lenton S; Degenhardt L; Farrell M; Ezard N, 2019, 'DRUG CHECKING AND OTHER HARM REDUCTION BEHAVIOURS REPORTED BY PEOPLE WHO USE ECSTASY: FINDINGS FROM THE ECSTASY AND RELATED DRUGS REPORTING SYSTEM 2019', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S81 - S81, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100203&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reilly R; Wand H; McKetin R; Ezard N; Dunlop AJ; Conigrave KM; Quinn B; Gray D; Wilkes E; Treloar C; Fisher I; Longbottom W; Ward J, 2019, 'METHODS OF DATA COLLECTION AND CHARACTERISTICS OF A SAMPLE OF METHAMPHETAMINE USERS: FINDINGS FROM THE NOVEL INTERVENTIONS TO ADDRESS METHAMPHETAMINE USE IN ABORIGINAL AND TORRES STRAIT ISLANDER COMMUNITIES SURVEY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S86 - S87, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100217&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Acheson LS; Murray E; Clifford B; Siefried KJ; Matthews GV; Ezard N, 2019, 'OPTIMISING CARE FOR PEOPLE WHO INJECT DRUGS: A RETROSPECTIVE MEDICAL RECORD REVIEW OF STAPHYLOCOCCUS AUREUS BACTERAEMIA TREATMENT', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S22 - S23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mitchell S; Nguyen QA; Peacock A; Ezard N, 2019, 'TOWARDS A PROMPT RESPONSE NETWORK FOR AUSTRALIA: RAPID HEALTH COMMUNICATION ABOUT EVENTS RELATED TO EMERGING DRUGS OF CONCERN', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S73 - S73, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100184&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bolton A; Harris M; Spooner C; Ezard N, 2019, 'Caring for people who regularly use methamphetamine in general practice: barriers and enablers to the provision of structured healthcare', in AUSTRALIAN JOURNAL OF PRIMARY HEALTH, CSIRO PUBLISHING, Vol. 25, pp. IX - X

Bruno R; Ezard N; Dunlop AJ; Clifford B; Carr A; Lintzeris N, 2017, 'COGNITIVE EFFECTS OF ESCALATING DOSES OF ORAL LISDEXAMFETAMINE IN METHAMPHETAMINE DEPENDENT ADULTS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 36, pp. 23 - 23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424000500055&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ezard N; Webb B; Clifford B; Cecilio ME; Bruno R, 2017, 'DEVELOPMENT OF THE SUBSTANCE USE SEX INDEX - A NEW TOOL FOR BEHAVIOUR CHANGE MEASUREMENT IN DRUG TREATMENT STUDIES', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 36, pp. 31 - 31, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424000500078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ezard N; Dunlop AJ; Carr A; McKetin R; Ali R; White J; Bruno R; Dolan K; Clifford B; Lintzeris N, 2016, 'A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF LISDEXAMFETAMINE FOR THE TREATMENT OF METHAMPHETAMINE DEPENDENCE: THE LIMA STUDY PROTOCOL', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 35 - 36, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500097&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Van Gordon K; Malone V; Magee F; Clifford B; Ezard N, 2016, 'BARRIERS TO STIMULANT TREATMENT ACCESS FOR WOMEN WHO USE METHAMPHETAMINE IN INNER SYDNEY: A QUALITATIVE STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 71 - 72, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500195&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lintzeris N; Monds L; Shanahan M; Harrod M; Nielsen S; Haber PS; Dunlop AJ; Ezard N; Nghi P; Read P; Manzie R; Lenton S; Jauncey M; Trimmingham T; Cairnduff S; Dietze PM, 2016, 'IMPLEMENTING TAKE-HOME NALOXONE INTO ROUTINE CARE IN DRUG AND ALCOHOL TREATMENT SERVICES, NEEDLE SYRINGE PROGRAMS AND PEER OUTREACH SERVICES IN NEW SOUTH WALES', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 10 - 10, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page